FDA "Approvables" Could Be Crawford's First Approval Challenge At FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA's backlog of 51 pending "approvable" NDAs and supplemental NDAs will provide one quantifiable marker to use in measuring the impact of a commissioner appointment.